Calamos Wealth Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-5,887
Closed -$377K 243
2018
Q4
$377K Sell
5,887
-633
-10% -$46.7K 0.06% 173
2018
Q3
$583K Sell
6,520
-286
-4% -$25.3K 0.07% 149
2018
Q2
$541K Sell
6,806
-354
-5% -$29.4K 0.07% 148
2018
Q1
$639K Sell
7,160
-11,154
-61% -$1.07M 0.08% 141
2017
Q4
$1.91M Sell
18,314
-406
-2% -$45.8K 0.25% 80
2017
Q3
$2.73M Sell
18,720
-23
-0.1% -$3.13K 0.38% 79
2017
Q2
$2.43M Sell
18,743
-245
-1% -$30K 0.34% 86
2017
Q1
$2.36M Sell
18,988
-1,841
-9% -$220K 0.35% 86
2016
Q4
$2.41M Sell
20,829
-856
-4% -$95.3K 0.39% 79
2016
Q3
$2.27M Sell
21,685
-3,445
-14% -$373K 0.39% 82
2016
Q2
$2.48M Sell
25,130
-607
-2% -$62.8K 0.44% 71
2016
Q1
$2.58M Sell
25,737
-1,797
-7% -$185K 0.5% 59
2015
Q4
$3.3M Sell
27,534
-254
-0.9% -$29.4K 0.66% 43
2015
Q3
$3.01M Buy
27,788
+796
+3% +$98.8K 0.72% 39
2015
Q2
$3.12M Buy
26,992
+1,896
+8% +$217K 0.74% 37
2015
Q1
$2.89M Buy
25,096
+518
+2% +$61.9K 0.72% 39
2014
Q4
$2.75M Sell
24,578
-12,152
-33% -$1.28M 0.79% 32
2014
Q3
$3.48M Buy
36,730
+1,009
+3% +$91.1K 1% 19
2014
Q2
$3.07M Buy
35,721
+545
+2% +$41.4K 0.88% 27
2014
Q1
$2.46M Sell
35,176
-1,008
-3% -$79.8K 0.73% 40
2013
Q4
$3.06M Sell
36,184
-290
-0.8% -$22.9K 0.94% 25
2013
Q3
$2.81M Buy
36,474
+6,026
+20% +$422K 0.92% 30
2013
Q2
$1.78M Buy
+30,448
New +$1.83M 0.63% 59

Other funds holding CELG

Calamos Wealth Management's CELG Position: Q1 2019 in Review

Calamos Wealth Management sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 5,887 shares — an estimated $377K sold.

Calamos Wealth Management first reported a position in CELG in Q2 2013 and held it in 23 quarters. The position peaked at $3.48M in Q3 2014. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

  • Calamos Wealth Management reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
  • Calamos Wealth Management sold 5,887 Celgene Corp shares in Q1 2019, an estimated $377K.
  • Calamos Wealth Management first reported a position in Celgene Corp in Q2 2013 and held it in 23 quarters.
  • Calamos Wealth Management's Celgene Corp position peaked at $3.48M in Q3 2014.
  • 1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on Calamos Wealth Management's 13F filing for Q1 2019, filed 12 Apr 2019.